Heart Disease Trials
Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.
Page 1 of 1 | Results 1 - 10 of 10
The purpose of this study is to demonstrate that Fractional Flow Reserve (FFR)-guided Percutaneous Coronary Intervention (PCI) is non-inferior to coronary artery bypass graft surgery (CABG) in patients with multi-vessel Coronary Artery Disease (CAD). FFF-guided PCI might result in lower rates of death, heart attack, and the need for repeat revascularization as compared to what was seen after CABG surgery. There is also the possibility of a chance at a shorter recovery time with the minimally invasive FFR-guided PCI versus CABG surgery.
Dr. Amir Lotfi
Heart
Baystate Medical Center 759 Chestnut Street Springfield, MA 01199
Amir Lotfi, MD
Heart
Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199
The purpose of this study is to gather additional information on CorMatrix ECM for Pericardial Closure. This device has received FDA clearance and is intended to close and repair of the sac surrounding the heart during cardiac surgery.
David Deaton, MD
Surgery,
Heart
Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199
The purpose of this study is to evaluate the safety and performance of the CytoSorb®device to reduce plasma free hemoglobin when used intraoperatively with cardiopulmonary bypass (CPB) in subjects undergoing cardiac surgery.
Richard Engelman, MD
Surgery,
Heart
Baystate Medical Center
759 Chestnut Street
Evan Lau, MD
Heart
Davis Family Heart & Vascular Center
Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199
Amir Lofti, MD
Heart
Davis Family Heart & Vascular Center
Baystate Medical Center
759 Chestnut Street Springfield, MA 01199
The objective of this study is to assess the safety and effectiveness of the Endologix® EndoVascular Aneurysm Sealing System for the repair of abdominal aortic aneurysms (AAA).
Neal Hadro, MD
Heart
Baystate Medical Center
759 Chestnut St.
Springfield, MA 01199
The purpose of this study is to test the efficacy of 4 mg Pitavastatin daily on cardiovascular-related events among HIV-1 infected adults.
Daniel J. Skiest, MD
HIV,
Heart
Baystate Infectious Diseases Clinical Research
3300 Main Street
Springfield, MA 01199
The purpose of this study is to demonstrate that the safety and effectiveness of the Medtronic Transcatheter Aortic Valve Replacement (TAVR) system as measured by rates of all-cause mortality or disabling stroke at two years is non-inferior to Surgical Aortic Valve Replacement (SAVR) in the treatment of severe aortic stenosis in subjects who have a low predicted risk of operative mortality for SAVR.
Dr. Ashequl Islam
Heart
Baystate Medical Center 759 Chestnut Street, Springfield, MA 01199
The purpose of this research study is to see if we can accurately measure the severity of your breathlessness.
Howard Smithline, MD
Heart
Baystate Medical Center Emergency Room
759 Chestnut Street
Springfield, MA 01199
Page 1 of 1 | Results 1 - 10 of 10